{
    "organizations": [],
    "uuid": "60c087c304b4c5643d15b7aaad1b25cd2abd45de",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-spectrum-pharma-q4-loss-per-share/brief-spectrum-pharma-q4-loss-per-share-0-29-idUSASB0C916",
    "ord_in_thread": 0,
    "title": "BRIEF-Spectrum Pharma Q4 Loss Per Share $0.29",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Spectrum Pharmaceuticals Inc:\n* SPECTRUM PHARMACEUTICALS REPORTS FOURTH QUARTER 2017 AND FULL YEAR 2017 FINANCIAL RESULTS AND PIPELINE UPDATE\n* Q4 NON-GAAP LOSS PER SHARE $0.23\n* SEES FY 2018 REVENUE $90 MILLION TO $110 MILLION * Q4 REVENUE $28.6 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-07T05:38:00.000+02:00",
    "crawled": "2018-03-07T19:56:20.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "spectrum",
        "pharmaceutical",
        "inc",
        "spectrum",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "pipeline",
        "update",
        "q4",
        "loss",
        "per",
        "share",
        "see",
        "fy",
        "revenue",
        "million",
        "million",
        "q4",
        "revenue",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}